224 related articles for article (PubMed ID: 24410859)
1. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.
Segelman J; Akre O; Gustafsson UO; Bottai M; Martling A
Colorectal Dis; 2014 May; 16(5):359-67. PubMed ID: 24410859
[TBL] [Abstract][Full Text] [Related]
2. External validation of models predicting the individual risk of metachronous peritoneal carcinomatosis from colon and rectal cancer.
Segelman J; Akre O; Gustafsson UO; Bottai M; Martling A
Colorectal Dis; 2016 Apr; 18(4):378-85. PubMed ID: 26588669
[TBL] [Abstract][Full Text] [Related]
3. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for appendiceal and colorectal peritoneal metastases.
Enblad M; Graf W; Birgisson H
Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
[TBL] [Abstract][Full Text] [Related]
5. Variation in colorectal cancer treatment and survival: a cohort study covering the East Anglia region.
Warwick J; Will O; Allgood P; Miller R; Duffy S; Greenberg D
Colorectal Dis; 2013; 15(10):1243-52. PubMed ID: 23710604
[TBL] [Abstract][Full Text] [Related]
6. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
7. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.
Segelman J; Granath F; Holm T; Machado M; Mahteme H; Martling A
Br J Surg; 2012 May; 99(5):699-705. PubMed ID: 22287157
[TBL] [Abstract][Full Text] [Related]
8. Lymph nodes ratio is associated with the survival of colorectal cancer patients with peritoneal carcinomatosis.
Matsuda K; Hotta T; Takifuji K; Kobayashi Y; Tsuji T; Nagai Y; Horiuchi T; Yamaue H
Am Surg; 2011 May; 77(5):602-7. PubMed ID: 21679595
[TBL] [Abstract][Full Text] [Related]
9. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.
van Gijn W; van Stiphout RGPM; van de Velde CJH; Valentini V; Lammering G; Gambacorta MA; Påhlman L; Bujko K; Lambin P
Ann Oncol; 2015 May; 26(5):928-935. PubMed ID: 25609247
[TBL] [Abstract][Full Text] [Related]
10. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
Radespiel-Tröger M; Hohenberger W; Reingruber B
Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
[TBL] [Abstract][Full Text] [Related]
12. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
13. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
Klaver YL; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
[TBL] [Abstract][Full Text] [Related]
14. Individualized prediction of colon cancer recurrence using a nomogram.
Weiser MR; Landmann RG; Kattan MW; Gonen M; Shia J; Chou J; Paty PB; Guillem JG; Temple LK; Schrag D; Saltz LB; Wong WD
J Clin Oncol; 2008 Jan; 26(3):380-5. PubMed ID: 18202413
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study.
Cashin PH; Graf W; Nygren P; Mahteme H
Eur J Surg Oncol; 2012 Jun; 38(6):509-15. PubMed ID: 22475555
[TBL] [Abstract][Full Text] [Related]
17. A simple tumor load-based nomogram for surgery in patients with colorectal liver and peritoneal metastases.
Elias D; Faron M; Goéré D; Dumont F; Honoré C; Boige V; Malka D; Ducreux M
Ann Surg Oncol; 2014 Jun; 21(6):2052-8. PubMed ID: 24499829
[TBL] [Abstract][Full Text] [Related]
18. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
[TBL] [Abstract][Full Text] [Related]
19. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
[TBL] [Abstract][Full Text] [Related]
20. Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.
Nagata H; Ishihara S; Hata K; Murono K; Kaneko M; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Watanabe T
Ann Surg Oncol; 2017 May; 24(5):1269-1280. PubMed ID: 27995451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
